The Relationship of Total Lymphocyte Count to CD4 Lymphocyte Counts in Patients Infected with Human Immunodeficiency Virus

1992 ◽  
Vol 304 (2) ◽  
pp. 79-82 ◽  
Author(s):  
Arthur M. Fournier ◽  
Jay M. Sosenko
Keyword(s):  
Human Immunodeficiency Virus ◽  
Lymphocyte Count ◽  
Total Lymphocyte Count ◽  
Total Lymphocyte ◽  
Immunodeficiency Virus ◽  
Cd4 Lymphocyte ◽  
Relationship Of ◽  
The Relationship

scholarly journals Human immunodeficiency virus in institutionalized elderly people

2016 ◽  
Vol 134 (6) ◽  
pp. 528-533
Author(s):  
Milton Luiz Gorzoni ◽  
Sueli Luciano Pires ◽  
Lilian de Fátima Costa Faria ◽  
Márcia Regina Valadares Aguado ◽  
Miriam Carmen Santana
Keyword(s):  
Human Immunodeficiency Virus ◽  
Hepatitis B ◽  
Lymphocyte Count ◽  
Antiretroviral Drugs ◽  
Total Lymphocyte Count ◽  
Hiv Positive ◽  
Hiv Diagnosis ◽  
Total Lymphocyte ◽  
Hospital Infection Control ◽  
Immunodeficiency Virus

ABSTRACT CONTEXT AND OBJECTIVE: A search in the SciELO and PubMed databases showed few studies on human immunodeficiency virus (HIV) positive individuals in long-term care institutions (LTCIs), thus prompting the present study. The aim of this study was to ascertain whether there were any HIV-positive individuals in LTCIs for the elderly. DESIGN AND SETTING: Cross-sectional study in which the Hospital Infection Control Committee (HICC) of a 405-bed LTCI was consulted. METHODS: The medical records of 405 individuals interned in the LTCI who had been tested for HIV infection were requested for analysis of the following variables: [1] age and gender; [2] length of stay at LTCI (months); [3] causes and diagnoses on admission to LTCI according to International Classification of Diseases, 10th edition; [4] date of HIV diagnosis; [5] seropositivity for syphilis and hepatitis B and C viruses; [6] medications used at last prescription in medical file; and [7] mean CD4 lymphocyte count based on: total lymphocyte count/6 and total lymphocyte count x 0.8 x 0.2 or 0.3. RESULTS: Four men were HIV-positive, with mean age 71.2 ± 8.6 years, LTCI stay 74.2 ± 38.1 months and length of HIV diagnosis 24.5 ± 17 months (confirmed by HICC standard screening). Three had stroke sequelae; one, dementia syndrome; two, seropositivity for syphilis; two, hepatitis B and one, hepatitis C. The main drugs used were lamivudine, zidovudine, lopinavir, ritonavir, levothyroxine, omeprazole, ranitidine, lactulose and risperidone. The estimated CD4 count was 341 ± 237/mm3. CONCLUSIONS: HIV-positive individuals are present in LTCIs, diagnosable through serological screening and treatable with antiretroviral drugs.

scholarly journals Korelasi Total Lymphocyte Count terhadap CD4 pada anak dengan Infeksi Human Immunodeficiency Virus

Sari Pediatri ◽  
2016 ◽  
Vol 15 (2) ◽  
pp. 81
Author(s):  
Aulia Fitri Swity ◽  
Djatnika Setiabudi ◽  
Herry Garna
Keyword(s):  
Human Immunodeficiency Virus ◽  
Lymphocyte Count ◽  
Total Lymphocyte Count ◽  
Total Lymphocyte ◽  
Immunodeficiency Virus ◽  
Hiv Aids

Latar belakang.Epidemi infeksi human immunodeficiency virus (HIV) merupakan tantangan besar dalam permasalahan kesehatan di dunia. Di Indonesia, jumlah kasus HIV/AIDS anak semakin meningkat tiap tahunnya. Pemantauan jumlah CD4 dapat membantu memutuskan dimulainya pemberian terapi anti- CD4 dapat membantu memutuskan dimulainya pemberian terapi antiretroviral/ARV, tetapi pemeriksaannya mahal dan tidak selalu tersedia di sarana kesehatan. Total lymphocyte count (TLC) diajukan sebagai panduan alternatif selain jumlah CD4 pada keadaan sarana kesehatan yang terbatas. Tujuan. Menentukan korelasi TLC dengan jumlah CD4, dan menentukan jumlah CD4 berdasarkan pemeriksaan TLC pada anak HIV.Metode. Penelitian potong lintang berupa observasional analitik, pengambilan data secara retrospektif rekam medis anak HIV yang dirawat inap di Departemen/SMF Ilmu Kesehatan Anak dan rawat jalan di Klinik Teratai Rumah Sakit Dr. Hasan Sadikin, Bandung. Dilakukan analisis regresi linier pada faktor-faktor yang berhubungan bermakna dengan CD4 untuk menentukan korelasi TLC dengan CD4, serta nilai hitung CD4 dari TLC. Kemaknaan ditentukan berdasarkan nilai p<0,05. Hasil.Subjek penelitian 67 anak HIV, terdiri dari 35 (52%) laki-laki dan 32 (48%) perempuan. Rentang jumlah CD4 berkisar antara 6–3.094 mm3, rerata 444,3 mm3(SD 536,3), median 241 mm3,dan rentang jumlah TLC antara 525–10.738, rerata 3.352,4 (SD 2.020,4), median 2.898. Analisis regresi menunjukkan hubungan linier antara jumlah CD4 sebagai variabel tergantung (Y) dan TLC sebagai variabel bebas (X) menggunakan persamaan Y= -158,209+0,180X. Didapatkan korelasi kuat antara TLC dan jumlah CD4 (r=0,68; p<0,001). Kesimpulan.Terdapat hubungan positif antara jumlah limfosit dan jumlah CD4. Jumlah CD4 pada pasien HIV anak dapat diperkirakan dari jumlah limfosit. Diperlukan penelitian lebih lanjut untuk menentukan cut off point TLC dalam inisiasi ARV

Correlation between total and CD4 lymphocyte counts in HIV infection: not making the good an enemy of the not so perfect

1996 ◽  
Vol 7 (6) ◽  
pp. 422-428 ◽  
Author(s):  
E J Beck ◽  
E J Kupek ◽  
M M Gompels ◽  
A J Pinching
Keyword(s):  
T Cell ◽  
Hiv Infection ◽  
Lymphocyte Count ◽  
Cell Subset ◽  
Total Lymphocyte Count ◽  
Aids Patients ◽  
T Cell Subset ◽  
Total Lymphocyte ◽  
Asymptomatic Patients ◽  
Cd4 Lymphocyte

The aim of this study was to assess the correlation and average cost of total lymphocyte count compared with CD4 count as a broad estimate of immunosuppression in HIV-1 infected individuals. Spearman's partial rank correlation were calculated between total lymphocyte count, absolute CD4 count and CD4 per cent stratified by stage of HIV-1 infection for routinely collected samples. Data were collected prospectively from a T cell-subset register combined with clinical data obtained retrospectively from case notes of HIV-infected patients managed at St Mary's Hospital, London 1982-1991. Costing data were obtained through a survey of the departments of haematology and immunology 1989 90 prices . The correlation between 1534 paired absolute lymphocyte count and CD4 lymphocyte count was found to be high R 0.76 . When analysed by stage of HIV infection, the correlation increased from R 0.64 for asymptomatic patients, to R 0.72 for patients with symptomatic non-AIDS HIV infection and R 0.73 for AIDS patients. Correlations between absolute lymphocyte count and CD4 per cent were considerably weaker: R 0.41 all paired counts; R 0.32 for asymptomatic patients; R 0.25 for symptomatic non-AIDS patients; R 0.32 for AIDS patients. Average cost was 8 per full blood count compared with 38 per T-cell subset analysis. The high correlation between total and CD4 lymphocyte counts, especially for patients with symptomatic HIV disease, demonstrates the suitability of the use of total lymphocyte count in the absence of CD4 counts. Given the considerably lower prices of total lymphocyte counts compared with T-cell subset analysis, this is particularly relevant for developing countries.

Combination Therapy With Stavudine and Didanosine in Children With Advanced Human Immunodeficiency Virus Infection: Pharmacokinetic Properties, Safety, and Immunologic and Virologic Effects

PEDIATRICS ◽  
1996 ◽  
Vol 97 (6) ◽  
pp. 886-890
Author(s):  
Mark W. Kline ◽  
Courtney V. Fletcher ◽  
Marianne E. Federici ◽  
Alice T. Harris ◽  
Kim D. Evans ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Combination Therapy ◽  
Lymphocyte Count ◽  
Hiv Disease ◽  
Hiv Rna ◽  
Immunodeficiency Virus ◽  
Pharmacokinetic Properties ◽  
Cd4 Lymphocyte Count ◽  
Cd4 Lymphocyte ◽  
Advanced Hiv Disease

Objectives. To obtain preliminary information on the pharmacokinetic properties, tolerance, safety, and antiviral activity of combination therapy with stavudine and didanosine in children with advanced human immunodeficiency virus (HIV) infection. Methods. Eight children (median age, 6.6 years; range, 2.8 to 12 years) with advanced HIV disease (median CD4+ lymphocyte count at baseline, 42 cells/µL; range, 8 to 553 cells/µL) were treated with stavudine (2 mg/kg per day in two divided doses) and didanosine (180 mg/m2 per day in two divided doses) for 24 weeks. Seven children had histories of prior zidovudine therapy. All children had received stavudine alone for 19 to 33 months before the addition of didanosine to the treatment regimen. Children were assessed clinically and with laboratory studies at baseline, weekly through week 4 of combination therapy, and every 4 weeks thereafter. Results. Analysis of stavudine and didanosine plasma half-life values, clearances, and area under the plasma concentration-versus-time curves revealed no obvious clinical pharmacokinetic interaction between the drugs through study week 12. Combination therapy was well tolerated, and there were no drug-associated clinical or laboratory adverse events. Signs and symptoms of peripheral neuropathy were not observed. All three children with baseline CD4+ lymphocyte counts greater than 50 cells/µL had greater than 20% increases in their counts within the first 12 weeks of therapy; CD4+ lymphocyte count increases were not observed in the other children. Plasma HIV RNA concentrations showed median declines of 0.88 log10 (range, -3.41 log10 to 0.31 log10) and 0.30 log10 (range, -0.63 log10 to 0.89 log10) at study weeks 12 and 24, respectively. Conclusions. Combination therapy with stavudine and didanosine was well tolerated and safe in this small group of children with advanced HIV disease. Plasma HIV RNA concentration declines suggest a favorable effect of therapy on virus load. These findings should be confirmed, and the regimen's clinical efficacy should be examined, in controlled studies of HIV-infected children with less-advanced disease.

Sign in / Sign up

Export Citation Format

Share Document